[PDF][PDF] Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a …
J Clin Oncol, 2014•academia.edu
Purpose In Asian countries, paclitaxel once per week is used as second-line treatment in
advanced gastric cancer, including human epidermal growth factor receptor 2 (HER2)–
positive tumors. The role of anti-HER2 agents, including lapatinib, in this setting and
population is unclear.
advanced gastric cancer, including human epidermal growth factor receptor 2 (HER2)–
positive tumors. The role of anti-HER2 agents, including lapatinib, in this setting and
population is unclear.
Purpose
In Asian countries, paclitaxel once per week is used as second-line treatment in advanced gastric cancer, including human epidermal growth factor receptor 2 (HER2)–positive tumors. The role of anti-HER2 agents, including lapatinib, in this setting and population is unclear.
academia.edu